Invesco’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $736K | Buy |
56,158
+8,028
| +17% | +$105K | ﹤0.01% | 2988 |
|
2025
Q1 | $1.06M | Buy |
48,130
+4,695
| +11% | +$103K | ﹤0.01% | 2801 |
|
2024
Q4 | $1.16M | Sell |
43,435
-21,341
| -33% | -$570K | ﹤0.01% | 2853 |
|
2024
Q3 | $1.73M | Buy |
64,776
+42,532
| +191% | +$1.14M | ﹤0.01% | 2655 |
|
2024
Q2 | $401K | Buy |
22,244
+1,098
| +5% | +$19.8K | ﹤0.01% | 3356 |
|
2024
Q1 | $386K | Buy |
21,146
+4,618
| +28% | +$84.2K | ﹤0.01% | 3432 |
|
2023
Q4 | $181K | Sell |
16,528
-6,447
| -28% | -$70.5K | ﹤0.01% | 3576 |
|
2023
Q3 | $132K | Buy |
22,975
+11,252
| +96% | +$64.5K | ﹤0.01% | 3669 |
|
2023
Q2 | $90.9K | Sell |
11,723
-140
| -1% | -$1.09K | ﹤0.01% | 3729 |
|
2023
Q1 | $79.1K | Sell |
11,863
-1,004
| -8% | -$6.7K | ﹤0.01% | 3704 |
|
2022
Q4 | $115K | Buy |
12,867
+969
| +8% | +$8.66K | ﹤0.01% | 3780 |
|
2022
Q3 | $117K | Sell |
11,898
-64
| -0.5% | -$629 | ﹤0.01% | 3783 |
|
2022
Q2 | $96K | Sell |
11,962
-4,945
| -29% | -$39.7K | ﹤0.01% | 3866 |
|
2022
Q1 | $164K | Buy |
16,907
+390
| +2% | +$3.78K | ﹤0.01% | 3766 |
|
2021
Q4 | $252K | Buy |
+16,517
| New | +$252K | ﹤0.01% | 3653 |
|